Table 1.
Study population characteristics
| Patient characteristics | Total (n = 84) | Cohort A (n = 53) | Cohort B (n = 31) |
|---|---|---|---|
| Bilateral reconstruction, n (%) | 28 (33.3) | 20 (37.7) | 8 (25.8) |
| Age in years, mean±SD | 44.5±11.9 | 41.4±9.9 | 49.8±13.2 |
| Smokers, n (%) | 18 (21.4) | 9 (17.0) | 9 (29.0) |
| BMI, kg/m2, mean±SD | 22.1±2.8 | 22.0±3.0 | 22.2±2.5 |
| Follow-up in monthss, mean±SD | 9.7±3.9 | 9.6±3.9 | 9.8±4.0) |
| Breast cancer, n (%) | 48 (57.1) | 34 (64.2) | 14 (45.2) |
| Precancerosis/DCIS, n (%) | 16 (19.0) | 10 (18.9) | 6 (19.4) |
| Freedom from pain, n (%) | 77 (91.7) | 49 (92.5) | 28 (90.3) |
| Adjuvant chemotherapy, n (%) | 9 (10.7) | 6 (11.3) | 3 (9.7) |
| Adjuvant endocrine therapy, n (%) | 33 (39.3) | 27 (50.9) | 6 (19.4) |
| NSAID use, n (%) | 67 (79.8) | 42 (79.2) | 25 (80.6) |
| Complications* | 30 (35.7) | 18 (34.0) | 12 (38.7) |
*
Complications include loss of implant, any seroma, infection, rash and Baker grade III/IV capsular fibrosis. BMI, body mass index; DCIS, ductal carcinoma in situ; NSAID, non-steroidal anti-inflammatory drug.